• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钬纳米粒子:一种用于实体恶性肿瘤放射消融的新设备的制备和体外特性研究。

Holmium nanoparticles: preparation and in vitro characterization of a new device for radioablation of solid malignancies.

机构信息

Department of Radiology and Nuclear Medicine, Imaging Division, University Medical Centre Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.

出版信息

Pharm Res. 2010 Oct;27(10):2205-12. doi: 10.1007/s11095-010-0226-3. Epub 2010 Jul 31.

DOI:10.1007/s11095-010-0226-3
PMID:20680667
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2939345/
Abstract

PURPOSE

The present study introduces the preparation and in vitro characterization of a nanoparticle device comprising holmium acetylacetonate for radioablation of unresectable solid malignancies.

METHODS

HoAcAc nanoparticles were prepared by dissolving holmium acetylacetonate in chloroform, followed by emulsification in an aqueous solution of a surfactant and evaporation of the solvent. The diameter, surface morphology, holmium content, and zeta potential were measured, and thermal behavior of the resulting particles was investigated. The stability of the particles was tested in HEPES buffer. The r(2)* relaxivity of protons and mass attenuation coefficient of the nanoparticles were determined. The particle diameter and surface morphology were studied after neutron activation.

RESULTS

Spherical particles with a smooth surface and diameter of 78 ± 10 nm were obtained, and the particles were stable in buffer. Neutron irradiation did not damage the particles, and adequate amounts of activity were produced for nuclear imaging and radioablation of malignancies through intratumoral injections.

CONCLUSIONS

The present study demonstrates that HoAcAc nanoparticles were prepared using a solvent evaporation process. The particle diameter can easily be adapted and can be optimized for specific therapeutic applications and tumor types.

摘要

目的

本研究介绍了一种包含乙酰丙酮合钬的纳米颗粒装置的制备和体外特性,用于不可切除的实体恶性肿瘤的放射消融。

方法

通过将乙酰丙酮合钬溶解在氯仿中,然后在表面活性剂的水溶液中乳化并蒸发溶剂来制备 HoAcAc 纳米颗粒。测量了直径、表面形态、钬含量和 Zeta 电位,并研究了所得颗粒的热行为。在 HEPES 缓冲液中测试了颗粒的稳定性。测定了质子的 r(2)*弛豫率和纳米颗粒的质量衰减系数。研究了经中子激活后的颗粒直径和表面形态。

结果

得到了具有光滑表面和 78±10nm 直径的球形颗粒,并且颗粒在缓冲液中稳定。中子辐照没有损坏颗粒,并且通过肿瘤内注射可以产生足够的放射性活度用于核成像和恶性肿瘤的放射消融。

结论

本研究表明,使用溶剂蒸发法制备了 HoAcAc 纳米颗粒。可以轻松调整颗粒直径,并针对特定的治疗应用和肿瘤类型进行优化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c952/2939345/a9af29a67b2d/11095_2010_226_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c952/2939345/380ad0e981d0/11095_2010_226_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c952/2939345/37a2dc91cb5e/11095_2010_226_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c952/2939345/30ff4ee70455/11095_2010_226_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c952/2939345/d344dd0b0d05/11095_2010_226_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c952/2939345/a9af29a67b2d/11095_2010_226_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c952/2939345/380ad0e981d0/11095_2010_226_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c952/2939345/37a2dc91cb5e/11095_2010_226_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c952/2939345/30ff4ee70455/11095_2010_226_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c952/2939345/d344dd0b0d05/11095_2010_226_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c952/2939345/a9af29a67b2d/11095_2010_226_Fig5_HTML.jpg

相似文献

1
Holmium nanoparticles: preparation and in vitro characterization of a new device for radioablation of solid malignancies.钬纳米粒子:一种用于实体恶性肿瘤放射消融的新设备的制备和体外特性研究。
Pharm Res. 2010 Oct;27(10):2205-12. doi: 10.1007/s11095-010-0226-3. Epub 2010 Jul 31.
2
Microspheres with ultrahigh holmium content for radioablation of malignancies.用于恶性肿瘤放射性消融的超高钬含量微球。
Pharm Res. 2009 Jun;26(6):1371-8. doi: 10.1007/s11095-009-9848-8. Epub 2009 Feb 25.
3
Holmium-loaded PLLA nanoparticles for intratumoral radiotherapy via the TMT technique: preparation, characterization, and stability evaluation after neutron irradiation.通过TMT技术用于瘤内放射治疗的钬负载聚乳酸纳米粒子:中子辐照后的制备、表征及稳定性评估
Drug Dev Ind Pharm. 2008 Aug;34(8):796-806. doi: 10.1080/03639040801918623.
4
Radioactive holmium phosphate microspheres for cancer treatment.放射性钬磷酸盐微球治疗癌症。
Int J Pharm. 2018 Sep 5;548(1):73-81. doi: 10.1016/j.ijpharm.2018.06.036. Epub 2018 Jun 15.
5
Influence of neutron irradiation on holmium acetylacetonate loaded poly(L-lactic acid) microspheres.中子辐照对负载乙酰丙酮钬的聚(L-乳酸)微球的影响。
Biomaterials. 2002 Apr;23(8):1831-9. doi: 10.1016/s0142-9612(01)00309-x.
6
Production and characterization of 166Ho polylactic acid microspheres.166Ho聚乳酸微球的制备与表征
J Labelled Comp Radiopharm. 2016 Jan;59(1):24-9. doi: 10.1002/jlcr.3366. Epub 2015 Dec 22.
7
Radiotherapeutic bandage based on electrospun polyacrylonitrile containing holmium-166 iron garnet nanoparticles for the treatment of skin cancer.基于含有钬-166铁石榴石纳米颗粒的电纺聚丙烯腈的放射治疗绷带用于皮肤癌治疗。
ACS Appl Mater Interfaces. 2014 Dec 24;6(24):22250-6. doi: 10.1021/am506045k. Epub 2014 Dec 2.
8
Development and characterisation of polymeric microparticle of poly(d,l-lactic acid) loaded with holmium acetylacetonate.载钬乙酰丙酮多(D,L-丙交酯)的聚合物微球的制备与性能研究。
J Microencapsul. 2018 May;35(3):281-291. doi: 10.1080/02652048.2018.1477843. Epub 2018 Jun 14.
9
Production of GMP-grade radioactive holmium loaded poly(L-lactic acid) microspheres for clinical application.用于临床应用的GMP级载钬聚(L-乳酸)微球的生产。
Int J Pharm. 2006 Mar 27;311(1-2):69-74. doi: 10.1016/j.ijpharm.2005.12.034. Epub 2006 Jan 24.
10
Holmium-loaded poly(L-lactic acid) microspheres: in vitro degradation study.负载钬的聚(L-乳酸)微球:体外降解研究。
Biomacromolecules. 2006 Jul;7(7):2217-23. doi: 10.1021/bm060230r.

引用本文的文献

1
Potential Applications of Rare Earth Metal Nanoparticles in Biomedicine.稀土金属纳米粒子在生物医学中的潜在应用
Pharmaceuticals (Basel). 2025 Jan 24;18(2):154. doi: 10.3390/ph18020154.
2
The various therapeutic applications of the medical isotope holmium-166: a narrative review.医用同位素钬-166的各种治疗应用:一项叙述性综述。
EJNMMI Radiopharm Chem. 2019 Aug 5;4(1):19. doi: 10.1186/s41181-019-0066-3.
3
Review of Therapeutic Applications of Radiolabeled Functional Nanomaterials.放射性标记功能纳米材料治疗应用综述。

本文引用的文献

1
Critical evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the measurement of nanoparticles and protein aggregates.纳米颗粒跟踪分析(NTA)的纳米视野法在纳米颗粒和蛋白聚集体测量中的批判性评估。
Pharm Res. 2010 May;27(5):796-810. doi: 10.1007/s11095-010-0073-2. Epub 2010 Mar 4.
2
Cancer statistics, 2009.2009年癌症统计数据。
CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49. doi: 10.3322/caac.20006. Epub 2009 May 27.
3
Neutron activation of holmium poly(L-lactic acid) microspheres for hepatic arterial radio-embolization: a validation study.
Int J Mol Sci. 2019 May 10;20(9):2323. doi: 10.3390/ijms20092323.
4
Transarterial Radioembolization (TARE) Agents beyond Y-Microspheres.经动脉放射性栓塞(TARE)药物除 Y 微球之外。
Biomed Res Int. 2018 Dec 31;2018:1435302. doi: 10.1155/2018/1435302. eCollection 2018.
5
Iron Oxide Nanoradiomaterials: Combining Nanoscale Properties with Radioisotopes for Enhanced Molecular Imaging.氧化铁纳米放射材料:将纳米特性与放射性同位素相结合,以增强分子成像。
Contrast Media Mol Imaging. 2017 Nov 21;2017:1549580. doi: 10.1155/2017/1549580. eCollection 2017.
6
Nanovectorized radiotherapy: a new strategy to induce anti-tumor immunity.纳米载体化放疗:诱导抗肿瘤免疫的新策略。
Front Oncol. 2012 Oct 10;2:136. doi: 10.3389/fonc.2012.00136. eCollection 2012.
7
Radioactive holmium acetylacetonate microspheres for interstitial microbrachytherapy: an in vitro and in vivo stability study.放射性钬乙酰丙酮微球用于间质近距离放疗:体外和体内稳定性研究。
Pharm Res. 2012 Mar;29(3):827-36. doi: 10.1007/s11095-011-0610-7. Epub 2011 Nov 9.
8
Preparation and complex characterization of silica holmium sol-gel monoliths.硅基钬溶胶-凝胶整体柱的制备及综合特性研究。
J Mater Sci Mater Med. 2011 Jan;22(1):29-40. doi: 10.1007/s10856-010-4186-2. Epub 2010 Dec 5.
用于肝动脉放射性栓塞的钬聚(L-乳酸)微球的中子活化:一项验证研究。
Biomed Microdevices. 2009 Aug;11(4):763-72. doi: 10.1007/s10544-009-9291-y.
4
Microspheres with ultrahigh holmium content for radioablation of malignancies.用于恶性肿瘤放射性消融的超高钬含量微球。
Pharm Res. 2009 Jun;26(6):1371-8. doi: 10.1007/s11095-009-9848-8. Epub 2009 Feb 25.
5
FID sampling superior to spin-echo sampling for T2*-based quantification of holmium-loaded microspheres: theory and experiment.在基于T2*的钬负载微球定量分析中,快速成像探测(FID)采样优于自旋回波采样:理论与实验
Magn Reson Med. 2008 Dec;60(6):1466-76. doi: 10.1002/mrm.21785.
6
R2 and R2* mapping for sensing cell-bound superparamagnetic nanoparticles: in vitro and murine in vivo testing.用于检测细胞结合超顺磁性纳米颗粒的R2和R2*映射:体外和小鼠体内测试
Radiology. 2007 Nov;245(2):449-57. doi: 10.1148/radiol.2451061345. Epub 2007 Sep 11.
7
Factors affecting the sensitivity and detection limits of MRI, CT, and SPECT for multimodal diagnostic and therapeutic agents.影响多模态诊断与治疗剂的磁共振成像(MRI)、计算机断层扫描(CT)和单光子发射计算机断层扫描(SPECT)敏感性及检测限的因素。
Anticancer Agents Med Chem. 2007 May;7(3):317-34. doi: 10.2174/187152007780618153.
8
Transcatheter and ablative therapeutic approaches for solid malignancies.实体恶性肿瘤的经导管和消融治疗方法。
J Clin Oncol. 2007 Mar 10;25(8):978-86. doi: 10.1200/JCO.2006.09.8657.
9
Hybrid scatter correction applied to quantitative holmium-166 SPECT.应用于定量钬-166单光子发射计算机断层扫描的混合散射校正。
Phys Med Biol. 2006 Oct 7;51(19):4773-87. doi: 10.1088/0031-9155/51/19/004. Epub 2006 Sep 8.
10
Long-term clinical outcome of phase IIb clinical trial of percutaneous injection with holmium-166/chitosan complex (Milican) for the treatment of small hepatocellular carcinoma.166钬/壳聚糖复合物(米利坎)经皮注射治疗小肝细胞癌IIb期临床试验的长期临床结果
Clin Cancer Res. 2006 Jan 15;12(2):543-8. doi: 10.1158/1078-0432.CCR-05-1730.